These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 36555831)

  • 1. Melatonin as a Potential Approach to Anxiety Treatment.
    Repova K; Baka T; Krajcirovicova K; Stanko P; Aziriova S; Reiter RJ; Simko F
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders.
    Giri A; Mehan S; Khan Z; Das Gupta G; Narula AS; Kalfin R
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3867-3895. PubMed ID: 38225412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin: new places in therapy.
    Maharaj DS; Glass BD; Daya S
    Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of the pineal hormone melatonin with oxygen-centered free radicals: a brief review.
    Reiter RJ
    Braz J Med Biol Res; 1993 Nov; 26(11):1141-55. PubMed ID: 8136717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.
    Pandi-Perumal SR; BaHammam AS; Brown GM; Spence DW; Bharti VK; Kaur C; Hardeland R; Cardinali DP
    Neurotox Res; 2013 Apr; 23(3):267-300. PubMed ID: 22739839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buspirone along with melatonin attenuates oxidative damage and anxiety-like behavior in a mouse model of immobilization stress.
    Kumar A; Kaur G; Rinwa P
    Chin J Nat Med; 2014 Aug; 12(8):582-9. PubMed ID: 25156283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin: Current evidence on protective and therapeutic roles in gynecological diseases.
    Hosseinzadeh A; Alinaghian N; Sheibani M; Seirafianpour F; Naeini AJ; Mehrzadi S
    Life Sci; 2024 May; 344():122557. PubMed ID: 38479596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin: the placental antioxidant and anti-inflammatory.
    Joseph TT; Schuch V; Hossack DJ; Chakraborty R; Johnson EL
    Front Immunol; 2024; 15():1339304. PubMed ID: 38361952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin: A Neurotrophic Factor?
    Miranda-Riestra A; Estrada-Reyes R; Torres-Sanchez ED; Carreño-García S; Ortiz GG; Benítez-King G
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Melatonergic System in Anxiety Disorders and the Role of Melatonin in Conditional Fear.
    Huang F; Yang Z; Li CQ
    Vitam Horm; 2017; 103():281-294. PubMed ID: 28061973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation.
    Reiter RJ
    Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical implications of melatonin: receptor-mediated and receptor-independent actions.
    Reiter RJ; Tan DX; Manchester LC; Pilar Terron M; Flores LJ; Koppisepi S
    Adv Med Sci; 2007; 52():11-28. PubMed ID: 18217386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic Effects of Melatonin.
    Mahmood D
    Drug Res (Stuttg); 2019 Feb; 69(2):65-74. PubMed ID: 30060265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral and central effects of melatonin on blood pressure regulation.
    Pechanova O; Paulis L; Simko F
    Int J Mol Sci; 2014 Oct; 15(10):17920-37. PubMed ID: 25299692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis.
    Hosseinzadeh A; Pourhanifeh MH; Amiri S; Sheibani M; Irilouzadian R; Reiter RJ; Mehrzadi S
    Pharmacol Rep; 2024 Feb; 76(1):25-50. PubMed ID: 37995089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites.
    Reiter RJ; Tan DX; Jou MJ; Korkmaz A; Manchester LC; Paredes SD
    Neuro Endocrinol Lett; 2008 Aug; 29(4):391-8. PubMed ID: 18766165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pineal melatonin exhibits more pronounced antistressor properties than anxiolytic diazepam].
    Arushanian EB; Beĭer EV; Bulgakova AS
    Eksp Klin Farmakol; 2007; 70(6):9-12. PubMed ID: 18318187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart.
    Reiter RJ; Tan DX
    Cardiovasc Res; 2003 Apr; 58(1):10-9. PubMed ID: 12667942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam.
    Ochoa-Sanchez R; Rainer Q; Comai S; Spadoni G; Bedini A; Rivara S; Fraschini F; Mor M; Tarzia G; Gobbi G
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):318-25. PubMed ID: 22789661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Melatonin as a drug: present status and perspectives].
    Arushanian ÉB
    Eksp Klin Farmakol; 2014; 77(6):39-44. PubMed ID: 25102735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.